The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-((5-Bromo-2-((2,4-dimethylphenyl)amino)pyrimidin-4-yl)oxy)-N-methylbenzamide ID: ALA4762124
PubChem CID: 162660422
Max Phase: Preclinical
Molecular Formula: C20H19BrN4O2
Molecular Weight: 427.30
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)c1ccccc1Oc1nc(Nc2ccc(C)cc2C)ncc1Br
Standard InChI: InChI=1S/C20H19BrN4O2/c1-12-8-9-16(13(2)10-12)24-20-23-11-15(21)19(25-20)27-17-7-5-4-6-14(17)18(26)22-3/h4-11H,1-3H3,(H,22,26)(H,23,24,25)
Standard InChI Key: IAYVYZLZMQDDQJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
22.5065 -10.0873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5053 -10.9146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2201 -11.3275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2183 -9.6745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9336 -10.0836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9324 -10.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6493 -11.3319 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.6517 -9.6658 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
25.3731 -10.0857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3719 -10.9146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0880 -11.3284 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.8058 -10.9144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8030 -10.0823 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.0864 -9.6723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5208 -11.3259 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.2347 -10.9124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2198 -12.1525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5052 -12.5647 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.9341 -12.5652 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.5049 -13.3897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9483 -11.3284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6616 -10.9156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6609 -10.0898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9408 -9.6784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2304 -10.0936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3743 -9.6753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9469 -12.1534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 1 0
9 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 1 0
3 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
16 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 16 1 0
23 26 1 0
21 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 427.30Molecular Weight (Monoisotopic): 426.0691AlogP: 4.75#Rotatable Bonds: 5Polar Surface Area: 76.14Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.92CX Basic pKa: 1.72CX LogP: 5.13CX LogD: 5.13Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.61Np Likeness Score: -1.58
References 1. Sun D,Yang Z,Zhen Y,Yang Y,Chen Y,Yuan Y,Zhang L,Zeng X,Chen L. (2020) Discovery of 5-bromo-4-phenoxy-N-phenylpyrimidin-2-amine derivatives as novel ULK1 inhibitors that block autophagy and induce apoptosis in non-small cell lung cancer., 208 [PMID:32961380 ] [10.1016/j.ejmech.2020.112782 ]